treatment R

• Completed NCT NCT00130923

  Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

  Not yet reported Dartmouth-Hitchcock Medical Center 95 participants Est. completion 2010-07 8 sites
  Other conditions: Schizophrenia, Psychotic Disorders, Substance Abuse, Alcohol Abuse
  View official trial listing →
• Completed NCT NCT00372892

  Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

  Not yet reported Hamilton Health Sciences Corporation 60 participants Est. completion 2011-06 7 sites
  Other conditions: Purpura, Thrombocytopenic, Idiopathic
  View official trial listing →
• Completed NCT NCT00540722

  Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

  Not yet reported National Cancer Institute (NCI) 56 participants Est. completion 2012-06 8 sites
  Obstructive sleep apnea Other conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Recurrent Adult Brain Tumor
  View official trial listing →
• Completed NCT NCT00544596

  R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer

  Not yet reported National Cancer Institute (NCI) 27 participants 4 sites
  Other conditions: Extensive Stage Small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
  View official trial listing →
• Completed NCT NCT00644124

  Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

  Not yet reported Sanofi 25 participants Est. completion 2011-10 1 site Stand-alone
  Other conditions: Lymphoma, Non-Hodgkin
  View official trial listing →
• Completed NCT NCT00711828

  Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma

  Not yet reported Mayo Clinic 21 participants Est. completion 2018-04-06 2 sites
  Obstructive sleep apnea Other conditions: Nodal Marginal Zone Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia
  View official trial listing →
• Completed NCT NCT00773955

  R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

  Not yet reported National Cancer Institute (NCI) 15 participants Est. completion 2010-08 1 site
  Other conditions: Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
  View official trial listing →
• Completed NCT NCT00842595

  Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

  Not yet reported French Innovative Leukemia Organisation 50 participants Est. completion 2010-05 1 site
  Other conditions: Diffuse Large B-Cell Lymphoma
  View official trial listing →
• Completed NCT NCT00848016

  Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery

  Not yet reported National Cancer Institute (NCI) 29 participants Est. completion 2012-06 2 sites
  Other conditions: Recurrent Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
  View official trial listing →
• Completed NCT NCT01452542

  A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

  Not yet reported Genzyme, a Sanofi Company 22 participants Est. completion 2011-11 1 site Stand-alone
  Other conditions: Healthy Volunteer
  View official trial listing →
• Completed NCT NCT02068690

  Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809

  Not yet reported Boehringer Ingelheim 83 participants Est. completion 2014-09-10 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Active, not recruiting NCT NCT02337985

  Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

  Not yet reported City of Hope Medical Center 10 participants Est. completion 2026-09-08 1 site
  Other conditions: AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, HIV Infection, AIDS Related Non-Hodgkin Lymphoma
  View official trial listing →
• Completed NCT NCT02572752

  Relative Bioavailability of 2 Oral Formulations of Nintedanib

  Not yet reported Boehringer Ingelheim 70 participants Est. completion 2015-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03004404

  To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers

  Not yet reported Boehringer Ingelheim 84 participants Est. completion 2017-08-15 1 site Stand-alone
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT03151499

  Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

  Not yet reported Boehringer Ingelheim 15 participants Est. completion 2017-07-11 1 site
  Other conditions: Healthy
  View official trial listing →
• Active, not recruiting NCT NCT03220022

  Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

  Not yet reported National Cancer Institute (NCI) 46 participants Est. completion 2027-07-16 19 sites
  Other conditions: AIDS-Related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
  View official trial listing →
• Completed NCT NCT03505151

  This Study in Healthy Men and Women Tests How the Body Takes up BI 409306

  Not yet reported Boehringer Ingelheim 9 participants Est. completion 2018-05-19 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03629054

  This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

  Not yet reported Boehringer Ingelheim 30 participants Est. completion 2018-11-05 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03629067

  Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

  Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2018-12-27 1 site Stand-alone
  Other conditions: Pharmacokinetics
  View official trial listing →
• Completed NCT NCT03783000

  A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet

  Not yet reported Boehringer Ingelheim 6 participants Est. completion 2019-03-06 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03804671

  A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet

  Not yet reported Boehringer Ingelheim 6 participants Est. completion 2019-03-26 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03817619

  Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet

  Not yet reported Radboud University Medical Center 11 participants Est. completion 2019-07-30 1 site
  Other conditions: Hepatitis C, Deglutition Disorders
  View official trial listing →
• Completed NCT NCT03818607

  A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH

  Not yet reported Amgen 42 participants Est. completion 2022-07-12 24 sites
  Other conditions: Paroxysmal Nocturnal Hemoglobinuria
  View official trial listing →
• Completed NCT NCT03837964

  A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

  Not yet reported Boehringer Ingelheim 12 participants Est. completion 2019-04-24 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03864666

  Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 28 participants Est. completion 2019-05-03 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT03871595

  A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2019-04-24 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03904576

  A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms

  Not yet reported Boehringer Ingelheim 20 participants Est. completion 2019-08-29 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04011241

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2019-09-06 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT04058470

  Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

  Not yet reported, Not yet reported Huiqiang Huang 140 participants Est. completion 2025-12-30 1 site
  Other conditions: Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb, Transformed Lymphoma, EBV-Positive DLBCL, Nos, ALK-Positive Anaplastic Large Cell Lymphoma
  View official trial listing →
• Status unknown NCT NCT04592822

  A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

  Not yet reported Hong Kong WD Pharmaceutical Co., Limited 20 participants Est. completion 2021-12-06
  Other conditions: Anticoagulant
  View official trial listing →
• Completed NCT NCT04619251

  A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood

  Not yet reported Boehringer Ingelheim 74 participants Est. completion 2021-08-03 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04674826

  A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

  Not yet reported LEO Pharma 101 participants Est. completion 2021-12-29 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04714073

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2021-04-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04716894

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2021-04-01 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04725682

  Bioequivalence Study of Tacrolimus in Healthy Volunteers

  Not yet reported Food and Drug Administration (FDA) 67 participants Est. completion 2021-06-17 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT04739774

  Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)

  Not yet reported Chiesi Farmaceutici S.p.A. 24 participants Est. completion 2021-04-26 1 site Stand-alone
  Other conditions: Chronic Obstructive Pulmonary Disease
  View official trial listing →
• Completed NCT NCT04844424

  A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants

  Not yet reported Janssen Research & Development, LLC 115 participants Est. completion 2022-07-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04958252

  A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated

  Not yet reported Boehringer Ingelheim 56 participants Est. completion 2023-10-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05076409

  A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

  Not yet reported Boehringer Ingelheim 15 participants Est. completion 2022-01-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT05191862

  Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 19 participants Est. completion 2022-05-07 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT05203289

  A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection

  Not yet reported Boehringer Ingelheim 200 participants Est. completion 2022-08-29 2 sites
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05466734

  BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 25 participants Est. completion 2022-09-20 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT05515588

  A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2022-11-17 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05707403

  A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

  Not yet reported Boehringer Ingelheim 8 participants Est. completion 2023-03-28 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05723874

  A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2023-05-26 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05833139

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of Zongertinib (BI 1810631) in the Blood

  Not yet reported Boehringer Ingelheim 16 participants Est. completion 2023-06-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05879991

  A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body

  Not yet reported Boehringer Ingelheim 15 participants Est. completion 2023-10-19 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05896384

  A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

  Not yet reported Boehringer Ingelheim 32 participants Est. completion 2025-03-26 1 site
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT05934942

  A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

  Not yet reported Boehringer Ingelheim 29 participants Est. completion 2024-02-08 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05965167

  Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

  Not yet reported Entera Bio Ltd. 45 participants Est. completion 2026-02-08 1 site Stand-alone
  Other conditions: Hypoparathyroidism, Osteoporosis, Fractures, Bone, Other Disease
  View official trial listing →
• Completed NCT NCT05965583

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2023-10-24 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06041438

  A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2023-11-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06167265

  BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 40 participants Est. completion 2024-01-18 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT06360081

  A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers

  Not yet reported Boehringer Ingelheim 56 participants Est. completion 2024-07-15 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06367153

  A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

  Not yet reported Boehringer Ingelheim 18 participants Est. completion 2024-08-20 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06393127

  A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body

  Not yet reported Boehringer Ingelheim 64 participants Est. completion 2024-09-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06395610

  Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

  Not yet reported Chiesi Farmaceutici S.p.A. 24 participants Est. completion 2024-06-18 1 site Stand-alone
  Other conditions: Chronic Obstructive Pulmonary Disease
  View official trial listing →
• Completed NCT NCT06504862

  A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood

  Not yet reported Boehringer Ingelheim 32 participants Est. completion 2024-12-18 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06624072

  A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food

  Not yet reported Boehringer Ingelheim 15 participants Est. completion 2024-11-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06861829

  A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood

  Not yet reported Boehringer Ingelheim 12 participants Est. completion 2025-04-23 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT07250048

  A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood

  Not yet reported Boehringer Ingelheim 40 participants Est. completion 2026-03-02 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT07368569

  A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2026-03-17 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT07412015

  Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

  Not yet reported Chipscreen Biosciences, Ltd. 24 participants Est. completion 2026-05-28 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT07592884

  Rochester Forensic Assertive Community Treatment Model in Minnesota

  Not yet reported University of Rochester 40 participants Est. completion 2025-04-05 1 site
  Other conditions: Schizophrenia, Bipolar Disorder, Criminal Behavior
  View official trial listing →
• Not yet recruiting NCT NCT07837648

  A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different Ways

  Not yet reported Boehringer Ingelheim 30 participants Est. completion 2026-12-15
  Other conditions: Healthy
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT07412015

Also known as: treatment R, treatment R (dose 1), treatment R (dose 2)

No related coverage yet.